The High-Risk Leukemia/Lymphoma Fellowship provides advanced clinical training in the multidisciplinary management of children and adolescents whose leukemia or lymphoma requires treatment beyond standard chemotherapy.
Fellows gain exposure to hematopoietic cell transplantation, cellular immunotherapy, early-phase clinical trials, and novel oncology and transplant therapies through Seattle Children’s Hospital, the Ben Towne Center for Childhood Cancer Research, Fred Hutch Cancer Center, and the University of Washington. (Fred Hutch)
Eligibility Criteria:
- Applicants must be certified or eligible for certification by the American Board of Pediatrics in General Pediatrics.
- Applicants must be certified or eligible for certification in Pediatric Hematology/Oncology/BMT in the United States or Canada by the fellowship start date.
- Applicants must be eligible to obtain a medical licence in Washington State.
- Candidates should have an interest in caring for children and adolescents with high-risk leukemias and lymphomas.
- The program is intended for physicians seeking advanced experience in cellular immunotherapy, hematopoietic cell transplantation, experimental therapies, and complex leukemia and lymphoma care. (Fred Hutch)
Funding Details:
- Fellowship salary or stipend: Not specified on the official program page.
- Fellowship duration: Not specified on the official program page.
- The selected fellow will train within the Seattle Children’s, Fred Hutch Cancer Center, and University of Washington clinical and research environment.
- Applicants should contact the program directly for information about salary, benefits, appointment structure, visa sponsorship, and the exact training period.
Deadline:
- Application deadline: December 31, 2026.
- Fellowship start date: July 2027.
- Applications for the July 2026 intake are closed.
- Applications for the July 2027 intake are currently being accepted.
Further Information:
- The fellowship covers multidisciplinary management of high-risk pediatric leukemia and lymphoma, including patients who require treatment beyond conventional chemotherapy.
- Training includes exposure to hematopoietic cell transplantation, cellular immunotherapy, early-phase studies, and biologically driven experimental therapies.
- Program enquiries may be directed to Program Director Katherine Tarlock, MD, at katherine.tarlock@seattlechildrens.org.
- Application and administrative questions may be directed to Program Coordinator Irene Harun at irene.harun@seattlechildrens.org.
- Official fellowship information and application details: Visit the Fred Hutch High-Risk Leukemia/Lymphoma Fellowship page for eligibility requirements, application materials, faculty information, and contact details.